Validation of the Trifecta Scoring Metric in Vacuum-Assisted Mini-Percutaneous Nephrolithotomy: A Single-Center Experience
Authors:
- Efrem PozziEPEfrem Pozzi
- Matteo MalfattoMMMatteo Malfatto
- Matteo TurettiMTMatteo Turetti
- Carlo SilvaniCSCarlo Silvani
- Letizia Maria Ippolita JannelloLJLetizia Maria Ippolita Jannello
- Susanna GarbagnatiSGSusanna Garbagnati
- Gilda GalbiatiGGGilda Galbiati
- Stefano Paolo ZanettiSZStefano Paolo Zanetti
- Fabrizio LongoFLFabrizio Longo
- Elisa De LorenzisELElisa De Lorenzis
- Giancarlo AlboGAGiancarlo Albo
- Andrea SaloniaASAndrea Salonia
Open Access
- 16 November 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (22) , 6788
Abstract
Background: Scoring metrics to assess and compare outcomes of percutaneous nephrolithotomy (PCNL) are needed. We aim to evaluate prevalence and predictors of trifecta in a cohort of patients treated with vacuum-assisted mini-percutaneous nephrolithotomy (vmPCNL) for kidney stones. Methods: Data from 287 participants who underwent vmPCNL were analysed. Patients’ and stones’ characteristics as well as operative data were collected. Stone-free was defined as no residual stones. The modified Clavien classification was used to score postoperative complications. Trifecta was defined as stone-free status without complications after a single session and no auxiliary procedures. Descriptive statistics and logistic regression models tested the association between predictors and trifecta outcome. Results: After vmPCNL, 219 (76.3%) patients were stone-free, and 81 (28.2%) had postoperative complications (any Clavien). Of 287, 170 (59.2%) patients achieved trifecta criteria. Patients who achieved trifecta status had smaller stone volume (p < 0.001), a higher rate of single stones (p < 0.001), shorter operative time (p < 0.01), and a higher rate of single percutaneous tract (p < 0.01) than −trifecta patients. Trifecta status decreased with the number of calyces involved, being 77.1%, 18.8%, and 4.1% in patients with 1, 2, or 3 calyces with stones, respectively (p < 0.001). Multivariable logistic regression analysis showed that stone volume (OR 1.1, p = 0.02) and multiple calyces being involved (OR 2.8 and OR 4.3 for two- and three-calyceal groups, respectively, all p < 0.01) were independent unfavourable risk factors for trifecta after accounting for age, BMI, gender, operative time, and number of access tracts. Conclusions: Trifecta status was achieved in 6 out of 10 patients after vmPCNL. Stone distribution in multiple calyceal groups and stone volume were independent unfavourable risk factors for trifecta.Keywords
Funding Information
- Italian Ministry of Health—Current Research IRCCS
This publication has 26 references indexed in Scilit:
- Vacuum-assisted mini-percutaneous nephrolithotomy: a new perspective in fragments clearance and intrarenal pressure controlWorld Journal of Urology, 2020
- Use of a Novel Vacuum-Assisted Access Sheath in Minimally Invasive Percutaneous Nephrolithotomy: A Feasibility StudyJournal of Endourology, 2020
- Comparison of stone-free rates following shock wave lithotripsy, percutaneous nephrolithotomy, and retrograde intrarenal surgery for treatment of renal stones: A systematic review and network meta-analysisPLOS ONE, 2019
- Comparison among the available stone treatment techniques from the first European Association of Urology Section of Urolithiasis (EULIS) Survey: Do we have a Queen?PLOS ONE, 2018
- Outpatient Percutaneous Nephrolithotomy: The UC San Diego Health ExperienceJournal of Endourology, 2018
- Comparison of renal pelvic pressure and postoperative fever incidence between standard‐ and mini‐tract percutaneous nephrolithotomyThe Kaohsiung Journal of Medical Sciences, 2016
- The Most Reliable Preoperative Assessment of Renal Stone Burden as a Predictor of Stone-free Status After Flexible Ureteroscopy With Holmium Laser Lithotripsy: A Single-center ExperienceUrology, 2012
- Categorisation of Complications and Validation of the Clavien Score for Percutaneous NephrolithotomyEuropean Urology, 2012
- Incidence, Prevention, and Management of Complications Following Percutaneous NephrolitholapaxyEuropean Urology, 2012
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987